Brand Post December 9, 2023 AJAX TAKES A STAND AGAINST SOCIAL HATE Today Ajax’s men’s and women’s teams will play without names on the back of their jerseys. Three dots will be…
Brand Post December 8, 2023 WANTIFO Launches Hair Dryer DualCare with Advanced Plasma Ionic Tech NEW YORK, Dec. 8, 2023 /PRNewswire/ — Wantifo, leading the beauty tech industry, introduces the WANTIFO Hair Dryer DualCare, now…
Brand Post December 8, 2023 GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ — The critical 28th United Nations Climate Change Conference, or Conference of Parties (COP28) is…
Brand Post December 8, 2023 ROSEN, A LEADING LAW FIRM, Encourages Generac Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GNRC NEW YORK, Dec. 8, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Brand Post December 8, 2023 “Frozen” Composer Christophe Beck and Kristen Bell Reunite at Education Through Music-Los Angeles Gala LOS ANGELES, Dec. 8, 2023 /PRNewswire/ — On Tuesday, December 5, 2023, Education Through Music-Los Angeles (etmla.org) hosted its 18th Year Benefit…
Brand Post December 8, 2023 Global Citizen Forum hosts star studded line up, including Yusra Mardini, Nile Rodgers, and Craig David, to champion climate action Comedian Russell Peters presented prestigious Global Citizen Forum Award RAS AL KHAIMAH, United Arab Emirates, Dec. 8, 2023 /PRNewswire/ —…
Brand Post December 8, 2023 SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit LOS ANGELES, Dec. 8, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have…
Brand Post December 8, 2023 Citizen Capital Names Robert C. O’Brien and Zalmay M. Khalilzad Global Advisory Board Members OKLAHOMA CITY, Dec. 8, 2023 /PRNewswire/ — Citizen Capital, a global investment advisory firm, network capital provider, and merchant investor,…
Brand Post December 8, 2023 Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023 This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of…
Brand Post December 8, 2023 Madoff Trustee Requests Allocation of More Than $66 Million to Customer Fund and Court Approval to Distribute More Than $45 Million to BLMIS Customers with Allowed Claims NEW YORK and WASHINGTON, Dec. 8, 2023 /PRNewswire/ — Irving H. Picard, Securities Investor Protection Act (SIPA) Trustee for the…